|Eiger BioPharmaceuticals to Present at Two Upcoming Investor Conferences|
A live webcast of each presentation will be available on the
Eiger will also host one-on-one meetings with investors at The 24th Annual BioCentury NewsMakers in the
Eiger is a clinical-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for orphan diseases. We are committed to realizing the full value of promising research from academic research and collaborations, independent investigators, and the pharmaceutical industry to efficiently translate programs into the clinic. Through the repurposing of drugs for orphan diseases, our mission is to systematically reduce the time and cost of the drug development process to more rapidly deliver important medicines to patients. For additional information about Eiger and its clinical programs, please visit www.eigerbio.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-present-at-two-upcoming-investor-conferences-300508290.html